TODD E. SIMPSON

Insider Reports History

Location
Pasadena, CA
Signature
/s/ Celia E. Eckert, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by TODD E. SIMPSON:

Company Role Class Num Shares Value Price $ Report Date Ownership
Xencor Inc Director Common Stock 13,686 $143,839 $10.51 12 Jun 2025 Direct
Xencor Inc Director Stock Option (Right to Buy) 27,372 12 Jun 2025 Direct
Neoleukin Therapeutics, Inc. Director Stock Option (Right to Buy) 25,000 08 Jun 2023 Direct
Seagen Inc. Chief Financial Officer Common Stock 0 $229.00 14 Dec 2023 Direct
Seagen Inc. Chief Financial Officer Performance Stock Units 0 $229.00 14 Dec 2023 Direct
Seagen Inc. Chief Financial Officer Restricted Stock Units 0 $229.00 14 Dec 2023 Direct
Seagen Inc. Chief Financial Officer Stock Options (Right to Buy) 0 14 Dec 2023 Direct

Insider Reports Filed by TODD E. SIMPSON

Symbol Company Period Transactions Value $ Form Type Role Filing Time
XNCR Xencor Inc 12 Jun 2025 2 $0 4 Director 16 Jun 2025, 19:23
XNCR Xencor Inc 13 Mar 2025 1 $0 4 Director 13 Mar 2025, 19:03
XNCR Xencor Inc 13 Mar 2025 0 $0 3 Director 13 Mar 2025, 19:01
/report/000095017023070882-simpson-todd-e-2023-12-14 Seagen Inc. 14 Dec 2023 27 -$21,363,868 4 Chief Financial Officer 15 Dec 2023, 18:42
/report/000120331123000115-simpson-todd-e-2023-09-21 Seagen Inc. 21 Sep 2023 1 -$16,520 4 Chief Financial Officer 22 Sep 2023, 19:45
/report/000120331123000103-simpson-todd-e-2023-08-31 Seagen Inc. 31 Aug 2023 1 -$439,182 4 Chief Financial Officer 01 Sep 2023, 16:49
/report/000120331123000094-simpson-todd-e-2023-08-28 Seagen Inc. 28 Aug 2023 2 -$99,910 4 Chief Financial Officer 30 Aug 2023, 19:06
/report/000120331123000075-simpson-todd-e-2023-08-15 Seagen Inc. 15 Aug 2023 4 -$679,898 4 Chief Financial Officer 17 Aug 2023, 20:47
NGNE Neoleukin Therapeutics, Inc. 08 Jun 2023 1 $0 4 Director 09 Jun 2023, 16:28
/report/000089924323011217-simpson-todd-e-2023-04-10 Seagen Inc. 10 Apr 2023 6 -$8,755,841 4 Chief Financial Officer 12 Apr 2023, 19:50
/report/000089924323011214-simpson-todd-e-2023-04-05-restatement Seagen Inc. 05 Apr 2023 0 $0 4/A Chief Financial Officer 12 Apr 2023, 19:37
/report/000089924323010582-simpson-todd-e-2023-04-01 Seagen Inc. 01 Apr 2023 1 $0 4 Chief Financial Officer 04 Apr 2023, 20:46
/report/000089924323008013-simpson-todd-e-2023-03-09 Seagen Inc. 09 Mar 2023 5 -$5,619,027 4 Chief Financial Officer 10 Mar 2023, 15:11
/report/000120331123000020-simpson-todd-e-2023-02-27 Seagen Inc. 27 Feb 2023 1 -$3,650,600 4 Chief Financial Officer 28 Feb 2023, 18:24
/report/000120331123000018-simpson-todd-e-2023-02-16 Seagen Inc. 16 Feb 2023 3 -$4,827,514 4 Chief Financial Officer 21 Feb 2023, 18:35
/report/000089924322030212-simpson-todd-e-2022-08-31 Seagen Inc. 31 Aug 2022 2 -$646,379 4 Chief Financial Officer 01 Sep 2022, 18:09
/report/000120331122000055-simpson-todd-e-2022-08-15 Seagen Inc. 15 Aug 2022 3 -$334,813 4 Chief Financial Officer 17 Aug 2022, 21:19
NGNE Neoleukin Therapeutics, Inc. 12 May 2022 1 $0 4 Director 16 May 2022, 18:27
/report/000120331122000032-simpson-todd-e-2022-04-20 Seagen Inc. 20 Apr 2022 1 -$81,829 4 Chief Financial Officer 22 Apr 2022, 20:32
/report/000120331121000098-simpson-todd-e-2021-12-20 Seagen Inc. 20 Dec 2021 1 -$51,698 4 Chief Financial Officer 22 Dec 2021, 16:31
/report/000089924321043353-simpson-todd-e-2021-11-03 Seagen Inc. 03 Nov 2021 5 -$5,569,117 4 Chief Financial Officer 05 Nov 2021, 17:21
/report/000120331121000081-simpson-todd-e-2021-10-29 Seagen Inc. 29 Oct 2021 3 -$4,664,057 4 Chief Financial Officer 02 Nov 2021, 18:46
/report/000120331121000079-simpson-todd-e-2021-09-23 Seagen Inc. 23 Sep 2021 1 +$33,410 4 Chief Financial Officer 27 Sep 2021, 20:10
/report/000089924321034980-simpson-todd-e-2021-08-31 Seagen Inc. 31 Aug 2021 2 -$667,884 4 Chief Financial Officer 02 Sep 2021, 19:57
/report/000120331121000060-simpson-todd-e-2021-08-16 Seagen Inc. 16 Aug 2021 4 -$82,377 4 Chief Financial Officer 18 Aug 2021, 20:28
NGNE Neoleukin Therapeutics, Inc. 11 May 2021 1 $0 4 Director 13 May 2021, 17:38